Susquehanna International Group, LLP Checkpoint Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$1.02 - $10.6 $13,872 - $144,160	-13,600 Reduced 37.36%	22,800 $24,000
Q2 2022 Aug 15, 2022	SELL	$0.97 - $1.77 $16,005 - $29,205	-16,500 Reduced 31.19%	36,400 $37,000
Q1 2022 May 16, 2022	SELL	$1.53 - $3.25 $83,538 - $177,450	-54,600 Reduced 50.79%	52,900 $94,000
Q3 2021 Nov 15, 2021	BUY	$2.5 - $3.53 $60,250 - $85,073	24,100 Added 28.9%	107,500 $355,000
Q2 2021 Aug 11, 2021	BUY	$2.36 - $3.2 $196,824 - $266,880	83,400 New	83,400 $246,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $297M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.